Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Medicina (Kaunas, Lithuania)|June 2, 2021
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian CancerTadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2012
Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervixTadahiro Shoji, Eriko Takatori, Tatsunori Saito, et al.
Medicina (Kaunas, Lithuania)|June 2, 2021
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective StudyMasahiro Kagabu, Takayuki Nagasawa, Shunsuke Tatsuki, et al.
International Journal of Molecular Sciences|April 2, 2020
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future DirectionsMasahiro Kagabu, Takayuki Nagasawa, Chie Sato, et al.
International Journal of Clinical Oncology|March 7, 2015
Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovaryHiroaki Itamochi, Nao Oumi, Tetsuro Oishi, et al.
Cancers|November 14, 2023
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, et al.
International Journal of Clinical Oncology|March 16, 2013
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervixEriko Takatori, Tadahiro Shoji, Yasuko Suga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 30, 2011
Does severe anemia caused by dose-dense paclitaxel-Carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trialSeisuke Kumagai, Toru Sugiyama, Tadahiro Shoji, et al.
International Journal of Clinical Oncology|April 7, 2021
Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II studyMuneaki Shimada, Shinya Sato, Tadahiro Shoji, et al.
Anticancer Research|August 30, 2022
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective StudyShunsuke Tatsuki, Tadahiro Shoji, Marina Abe, et al.
Pageof 9